How you can pay a premium and still make great returns with high-quality ASX shares

High P/E stocks can more than justify the valuation if profit growth is strong.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Some of the best businesses trade at a high multiple of earnings
  • Strong profit growth can make up for a reducing P/E ratio or even keep that valuation stable
  • Names like Pro Medicus, Altium and TechnologyOne are examples of how this can work out well

ASX shares trade on a wide range of valuations. We can still make really good returns on ones with high price/earnings (P/E) ratios if they deliver strong profit growth.

It might be easy to say that a business with a high p/e ratio seems expensive and that a low one is cheap. But it's not that easy.

A P/E ratio is just a snapshot of what multiple of earnings the company is trading at compared to its share price.

The current P/E ratio might be useful to judge a business that doesn't see that much profit growth in each result, such as ANZ Group Holdings Ltd (ASX: ANZ). But a high P/E ratio may simply be reflecting the potential of future growth. The profit they make in FY25 could justify today's P/E ratio.

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.

Image source: Getty Images

Why a high P/E ratio can work out

When we think about ASX shares with high P/E ratios, names like Pro Medicus Ltd (ASX: PME), Altium Limited (ASX: ALU) and TechnologyOne Ltd (ASX: TNE) may come to mind.

Look at the last five years of capital growth of these companies.

The Pro Medicus share price has risen by 710%.

The Altium share price has gone up 85%.

The TechnologyOne share price has climbed 215%.

But if we look back five years, the P/E ratios of these businesses weren't exactly low.

The Pro Medicus share price was valued at 68 times FY18's earnings.

The Altium share price was valued at 52 times FY18's earnings.

The TechnologyOne share price was priced at 31 times FY18's earnings.

How have these companies managed to deliver such strong returns?

I'd suggest it's down to the fact that each of these businesses has delivered great profit growth which has justified the valuation.

If profit is growing really quickly, it can more than makeup for a reduction of the P/E ratio. For example, if profit grows by 20% in one year, but the P/E ratio only falls by 10%, then investors can get a pleasing double-digit share price return.

With the great ASX shares I've mentioned, the P/E ratio hasn't really deteriorated at all and their profit growth outlook is still very promising.

Winners keep on winning

I think one of the most important things to remember in investing is that great businesses usually don't just fall over suddenly. If they keep investing in their products and services and remain focused, they can keep winning year after year.

Just think about Microsoft, it's almost 50 years old and continues to have a very promising growth outlook.

Apple is well over 40 years old but keeps winning and innovating.

On the ASX, I think it's highly likely that many of the ASX shares that have done well are going to be able to keep growing profits. Though I'm not necessarily suggesting that today is the best day to buy into Pro Medicus shares.

Motley Fool contributor Tristan Harrison has positions in Altium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Altium, Apple, Microsoft, Pro Medicus, and Technology One. The Motley Fool Australia has recommended Apple, Pro Medicus, and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Investing Strategies

man holding two stacks of coins varying in size representing a comparison of dividend yields between Medibank and NIB
Blue Chip Shares

How are Australia's biggest ASX stocks really tracking in 2026?

Some blue chips lag while others surge, however opportunity remains.

Read more »

a group of smart looking kids, wearing formal clothes and all with spectacles, sit in a line and smile charmingly.
Blue Chip Shares

3 ASX 200 shares for smart investors in May

Let's see what could make these smart picks for the month ahead.

Read more »

Man with a rocket strapped to his back on a tiny bicycle ready to take off.
Growth Shares

2 ASX shares tipped to grow 90% or more in the next 12 months!

These stocks have the potential to deliver major returns!

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Growth Shares

Down 67%, is this ASX 300 share a bargain buy?

A sharp share price decline has reset expectations, but the underlying growth story and market opportunity have not changed.

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Cheap Shares

2 ASX 200 shares down 50% that I would buy today

Short-term pressure has weighed on these businesses, but their underlying positions may not have changed as much as the share…

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Growth Shares

2 high-quality ASX 200 shares experts rate as buys

These stocks are top-rated by some of Australia’s top brokers.

Read more »

Man holding fifty Australian Dollar banknotes in his hands, symbolising dividends.
Dividend Investing

3 star ASX dividend income stocks for the rest of 2026

I rate these businesses as strong income buys.

Read more »

Children skipping and jumping up a hill.
Dividend Investing

Want passive income? These ASX dividend shares offer 5%+ yields

These companies grow their payouts over time.

Read more »